RadNet, Inc. Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Loss
RadNet, Inc. (RDNT) reported Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Loss of $1.00 million for the 12-month period ending 2019-12-31, per its 10-K filed 2021-03-16.
Discontinued › Expense Statement › Operating Expenses
us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementLoss · last filed 2021-03-16
- RadNet, Inc. business combination, step acquisition, equity interest in acquiree, remeasurement loss for fiscal 2019 was $1.00M, a 66.46% decline from fiscal 2018.
- RadNet, Inc. business combination, step acquisition, equity interest in acquiree, remeasurement loss for fiscal 2018 was $2.99M.
| Period end | Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Loss 12 month |
|---|---|
| 2019-12-31 | $1.00M 10-K · filed 2021-03-16 |
| 2018-12-31 | $2.99M 10-K · filed 2020-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |